These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis. Amano N; Sato S; Murata A; Tsuzura H; Tomishima K; Sato S; Matsumoto K; Shimada Y; Iijima K; Harada K; Genda T Clin J Gastroenterol; 2020 Feb; 13(1):79-82. PubMed ID: 31286423 [TBL] [Abstract][Full Text] [Related]
23. The challenges of primary biliary cholangitis: What is new and what needs to be done. Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D; Vierling JM; Adams D; Alpini G; Banales JM; Beuers U; Björnsson E; Bowlus C; Carbone M; Chazouillères O; Dalekos G; De Gottardi A; Harada K; Hirschfield G; Invernizzi P; Jones D; Krawitt E; Lanzavecchia A; Lian ZX; Ma X; Manns M; Mavilio D; Quigley EM; Sallusto F; Shimoda S; Strazzabosco M; Swain M; Tanaka A; Trauner M; Tsuneyama K; Zigmond E; Gershwin ME J Autoimmun; 2019 Dec; 105():102328. PubMed ID: 31548157 [TBL] [Abstract][Full Text] [Related]
24. Autoimmune hepatitis associated with bile duct injury resembling chronic non-suppurative destructive cholangitis. Sato Y; Harada K; Sudo Y; Watanabe K; Nakahama T; Morimoto H; Nakanuma Y Pathol Int; 2002 Jul; 52(7):478-82. PubMed ID: 12167107 [TBL] [Abstract][Full Text] [Related]
25. Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Mitchison HC; Bassendine MF; Hendrick A; Bennett MK; Bird G; Watson AJ; James OF Hepatology; 1986; 6(6):1279-84. PubMed ID: 3793004 [TBL] [Abstract][Full Text] [Related]
26. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904 [TBL] [Abstract][Full Text] [Related]
27. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena? Davis PA; Leung P; Manns M; Kaplan M; Munoz SJ; Gorin FA; Dickson ER; Krawitt E; Coppel R; Gershwin ME Hepatology; 1992 Nov; 16(5):1128-36. PubMed ID: 1330864 [TBL] [Abstract][Full Text] [Related]
28. Primary Biliary Cholangitis and Autoimmune Hepatitis. Gonzalez RS; Washington K Surg Pathol Clin; 2018 Jun; 11(2):329-349. PubMed ID: 29751878 [TBL] [Abstract][Full Text] [Related]
29. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416 [TBL] [Abstract][Full Text] [Related]
30. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis]. Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705 [TBL] [Abstract][Full Text] [Related]
32. Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members. Caldwell SH; Leung PS; Spivey JR; Prindiville T; de Medina M; Saicheur T; Rowley M; Reddy KR; Coppel R; Jeffers LJ Hepatology; 1992 Oct; 16(4):899-905. PubMed ID: 1398496 [TBL] [Abstract][Full Text] [Related]
33. Mitochondrial pyruvate dehydrogenase complex subunits as autoantigens in human primary biliary cirrhosis. Adami P; Berrez JM; Latruffe N Biochem Int; 1991 Feb; 23(3):429-37. PubMed ID: 1877981 [TBL] [Abstract][Full Text] [Related]
34. Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid. Li CP; Tong MJ; Hwang SJ; Luo JC; Co RL; Tsay SH; Chang FY; Lee SD J Gastroenterol Hepatol; 2000 Jan; 15(1):95-8. PubMed ID: 10719755 [TBL] [Abstract][Full Text] [Related]
36. Two different subtypes of antimitochondrial antibodies are associated with primary biliary cirrhosis: identification and characterization by radioimmunoassay and immunoblotting. Manns M; Gerken G; Kyriatsoulis A; Trautwein C; Reske K; Meyer Zum Büschenfelde KH Hepatology; 1987; 7(5):893-9. PubMed ID: 2443436 [TBL] [Abstract][Full Text] [Related]
37. Antimitochondrial and antinuclear antibodies in primary biliary cirrhosis: an update in relation to their biochemical characterization and clinical significance. Brenard R; Geubel AP Acta Clin Belg; 1991; 46(5):305-12. PubMed ID: 1721757 [TBL] [Abstract][Full Text] [Related]
38. Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. Cassani F; Bianchi FB; Lenzi M; Volta U; Pisi E J Clin Pathol; 1985 Jul; 38(7):801-5. PubMed ID: 3894432 [TBL] [Abstract][Full Text] [Related]
39. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients. Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239 [TBL] [Abstract][Full Text] [Related]
40. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Ben-Ari Z; Dhillon AP; Sherlock S Hepatology; 1993 Jul; 18(1):10-5. PubMed ID: 8100797 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]